Saturday, May 25, 2013 Last update: Yesterday, 10:04 PM
Company Tech News as it Breaks
Trade Events
NeuroMetrix, Inc.
News articles for NeuroMetrix, Inc.:
Thursday, April 25, 2013
- NeuroMetrix Reports Q1 2013 ResultsNeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), today reported business and financial ... read more
Wednesday, April 24, 2013
- NeuroMetrix to Partner with Omron Healthcare for Distribution of NC-stat DPNCheck in JapanNeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), announced that it had entered ... read more
Wednesday, April 17, 2013
- NeuroMetrix, Inc. Announces Date for 2013 First Quarter Financial Results Conference CallNeuroMetrix, Inc. (Nasdaq: NURO), today said it plans to issue its 2013 first quarter financial results before the opening of the market on April 25, ... read more
Tuesday, March 12, 2013
- NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of KoreaNeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that ... read more
Tuesday, February 19, 2013
- NeuroMetrix Reports Q4 2012 ResultsNeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the ... read more
Friday, February 15, 2013
- NeuroMetrix Announces One-for-Six Reverse Stock SplitNeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced the effectiveness of a one-for-six reverse ... read more
Wednesday, January 30, 2013
- NeuroMetrix Launches Website for SENSUS™ Pain Management SystemNeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that is has launched a ... read more
Monday, January 7, 2013
- NeuroMetrix Announces Initial Commercial Shipment of SENSUS™ Pain Management SystemNeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it had ... read more
Wednesday, January 2, 2013
- NeuroMetrix to Present at 6th Annual OneMedForum San Francisco 2013NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that Shai N. ... read more
Thursday, November 29, 2012
- NeuroMetrix Completes 510(k) Clearance Process for SENSUS™ Pain Management SystemNeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported that it has received ... read more